Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.28
-0.34 (-2.93%)
At close: Sep 28, 2026, 4:00 PM EDT
11.28
0.00 (0.00%)
After-hours: Sep 28, 2026, 4:10 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $223.65 million as of September 28, 2026. Its market cap has decreased by -65.69% in one year.
Market Cap
223.65M
Enterprise Value
-18.23M
1-Year Change
-65.69%
Ranking
Category
Stock Price
$11.28
ChartMarket Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $223.65M, a decrease of -41.96%. That is a compound annual growth rate of -8.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 223.65M | -63.94% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 241.38M |
| Pyxis Oncology | 238.55M |
| MacroGenics | 238.24M |
| Yarrow Bioscience | 237.63M |
| Sionna Therapeutics | 236.46M |
| ProQR Therapeutics | 232.85M |
| Cue Biopharma | 228.18M |
| Compugen | 225.44M |